Codiak Presents Data at AACR 2021 Demonstrating Potential of Engineered Exosomes to Enhance the Therapeutic Index of Well-Validated Cancer Immunotherapy Pathways

NEXT STORY
HOOKIPA announces positive preliminary Phase 1 immunogenicity data for its immunotherapy candidates to treat advanced HPV16+ cancers
PREV STORY
Valneva Announces Publication of 2020 Universal Registration Document and Provides Business Updates
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Merus Announces Recent Corporate Developments and Financial Results for the First Quarter 2018

- Initiation of Phase 1, first-in-human clinical trial of MCLA-158 in patients with solid ...

author_avatar
NASDAQ Market News

One of a kind relationship violence training comes to San Diego

Professionals to become certified Relationship Violence Assessment and Response SpecialistsSAN DIEGO, Sept. 10, 2018 ...

author_avatar
NASDAQ Market News

FIT Biotech Oy: Conversion of FIT Biotech Oy’s Convertible Capital Notes into shares

FIT Biotech Oy Company release December 21, 2018 at 05:00 PM EET Conversion of ...

author_avatar
NASDAQ Market News